198 related articles for article (PubMed ID: 8347496)
1. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
Yamaguchi A; Nakagawara G; Kurosaka Y; Nishimura G; Yonemura Y; Miyazaki I
Br J Cancer; 1993 Aug; 68(2):399-402. PubMed ID: 8347496
[TBL] [Abstract][Full Text] [Related]
2. Correlation of p53 expression and proliferative activity in gastric cancer.
Yonemura Y; Fushida S; Tsugawa K; Ninomiya I; Fonseca L; Yamaguchi A; Miyazaki I; Urano T; Shiku H
Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis.
Yamaguchi A; Kurosaka Y; Fushida S; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Cancer; 1992 Dec; 70(12):2778-84. PubMed ID: 1451055
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
5. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
7. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
8. Large bowel cancer: surgical pathology and its relationship to survival.
Phillips RK; Hittinger R; Blesovsky L; Fry JS; Fielding LP
Br J Surg; 1984 Aug; 71(8):604-10. PubMed ID: 6743980
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in colorectal cancer].
Tominaga T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2202-8. PubMed ID: 3408254
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma.
Mulder JW; Baas IO; Polak MM; Goodman SN; Offerhaus GJ
Br J Cancer; 1995 Jun; 71(6):1257-62. PubMed ID: 7779721
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
13. The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome.
Rew DA; Karkera R; Mullee MA; Julious SA; Wilson GD
Eur J Surg Oncol; 1996 Oct; 22(5):508-15. PubMed ID: 8903495
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical detection of p53 in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1312-6. PubMed ID: 1435694
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of serum CYFRA21-1 in colorectal cancer].
Miyashita T; Nishimura G; Michiwa Y; Sato T; Tsugawa K; Fushida S; Sugiyama K; Fujimura T; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1693-6. PubMed ID: 8886047
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.
Flamini G; Curigliano G; Ratto C; Astone A; Ferretti G; Nucera P; Sofo L; Sgambato A; Boninsegna A; Crucitti F; Cittadini A
Eur J Cancer; 1996 May; 32A(5):802-6. PubMed ID: 9081357
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
19. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].
Zheng W; Zhang L; Wu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):679-683. PubMed ID: 30293393
[No Abstract] [Full Text] [Related]
20. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
